Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0A87 stock hub

LON/0A87 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0A87is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
38.6B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0A87
In the news

Latest news · LON/0A87

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E72.1
P25 n/aP50 n/aP75 n/a
ROE1.5
P25 n/aP50 n/aP75 n/a
ROIC2.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0A87 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
215
Groups with data
11
Currency
JPY
Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Japan
Country code
UK
Employees
47,455
Employees Change
-1,826%
Employees Change Percent
-3.71
Enterprise value
$60.9B
Exchange
London Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Isin
US8740602052
Last refreshed
2026-05-10
Market cap
$38.6B
Price
$17.88
Price currency
USD
Rev Per Employee
445,835.27x
Sic
2834
Symbol
lon/0A87
Website
https://www.takeda.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
1.39%
EV Earnings
113.86x
EV/EBIT
21.65x
EV/EBITDA
9.84x
EV/FCF
12.72x
EV/Sales
2.91x
FCF yield
12.41%
P/B ratio
1.07x
P/E ratio
72.11x
P/S ratio
1.82x
PE Ratio10 Y
54.57x
PE Ratio3 Y
53.83x
PE Ratio5 Y
40.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
13.51%
EBITDA Margin
28.53%
FCF margin
22.64%
Gross margin
65.52%
Gross Profit
$13.9B
Gross Profit Growth
-2.28%
Gross Profit Growth Q
8.7%
Gross Profit Growth3 Y
3.03%
Gross Profit Growth5 Y
7.41%
Net Income
$535.1M
Net Income Growth
-45.73%
Net Income Growth Q
335.66%
Net Income Growth3 Y
-25.63%
Net Income Growth5 Y
-8.97%
Pretax Margin
4.6%
Profit Margin
2.53%
Profit Per Employee
$11,277
ROA
2.47
Roa5y
2.47
ROCE
4.71
ROE
1.5
Roe5y
4.15
ROIC
2.76
Roic5y
4.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
28.34%
Cagr3y
4.63%
Cagr5y
2.57%
EPS Growth
-45.86
EPS Growth Q
330.2
EPS Growth3 Y
-26.17
EPS Growth5 Y
-9.3
FCF Growth
10.2%
FCF Growth Q
-2.08%
FCF Growth3 Y
3.23%
FCF Growth5 Y
8.15%
OCF Growth
6.78%
OCF Growth Q
-2.74%
OCF Growth10 Y
19.3%
OCF Growth3 Y
3.94%
OCF Growth5 Y
8.37%
Revenue Growth
-2.5x
Revenue Growth Q
4.16x
Revenue Growth3 Y
4.21x
Revenue Growth5 Y
6.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
$0.29
Assets
$73B
Cash
$3.1B
Current Assets
$14.6B
Current Liabilities
$12.2B
Debt
$25.7B
Debt EBITDA
$4.09
Debt Equity
$0.71
Debt FCF
$5.36
Equity
$36.2B
Interest Coverage
4.62
Liabilities
$36.8B
Long Term Assets
$58.4B
Long Term Liabilities
$24.6B
Net Cash
$-22.6B
Net Cash By Market Cap
$-58.54
Net Debt EBITDA
$3.74
Net Debt Equity
$0.62
Net Debt FCF
$4.72
Tangible Book Value
$-7.7B
Tangible Book Value Per Share
$-4.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.19
Inventory Turnover
1.16
Net Working Capital
$2.1B
Quick ratio
0.54
Working Capital
$2.4B
Working Capital Turnover
$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.25%
Dividend Growth
4.18%
Dividend Growth Years
1%
Dividend per share
$0.43
Dividend Years
3
Dividend Yield
2.4%
Ex Div Date
2025-09-30
Last Dividend
$0.2
Payout Ratio
277.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

33
MetricValue
1Y total return
28.32%
200-day SMA
13.89
3Y total return
14.54%
50-day SMA
14.03
50-day SMA vs 200-day SMA
50over200
5Y total return
13.5%
All Time High
19.92
All Time High Change
-10.27%
All Time High Date
2021-03-22
All Time Low
12.3
All Time Low Change
45.38%
All Time Low Date
2022-10-21
ATR
0.52
Ch YTD
23.98
High
17.88
High52
18.29
High52 Date
2026-03-31
High52ch
-2.27%
Low
17.88
Low52
14.05
Low52 Date
2025-10-21
Low52ch
27.23%
Ma50ch
27.4%
Price vs 200-day SMA
28.71%
RSI
70.22
RSI Monthly
63.47
RSI Weekly
74.35
Sharpe ratio
0.83x
Sortino ratio
1.64
Total Return
2.15%
Tr YTD
23.97
Tr1m
-0.9%
Tr3m
23.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$2.9B
Operating Income Growth
0.19
Operating Income Growth Q
963.6
Operating Income Growth3 Y
2.45
Operating Income Growth5 Y
20.07
Operating margin
13.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,578,176,279%
Net Borrowing
-827,838,449.2
Shares Insiders
0.11%
Shares Institutions
47.15%
Shares Qo Q
1.77%
Shares Yo Y
0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$4.5B
Average Volume
887.7x
Bv Per Share
22.93
CAPEX
$-845.6M
Ch1m
-0.9
Ch1y
28.32
Ch3m
23.98
Ch3y
6.3
Ch5y
3.62
Ch6m
18.69
Change
-1.35%
Change From Open
0
Close
18.12
Days Gap
-1.35
Depreciation Amortization
3,140,515,051.8
Dollar Volume
18,196.8
Earnings Date
2026-05-13
EBIT
$2.9B
EBITDA
$6B
EPS
$0.33
F Score
6
FCF
$4.8B
FCF EV Yield
7.86x
Financing CF
-3,417,303,309
Fiscal Year End
March
Founded
1,781
Goodwill
26,937,104,924.7
Graham Number
9.67363
Graham Upside
-45.88
Income Tax
$436.8M
Investing CF
-1,567,646,191
Is Primary Listing
0
Last Earnings Date
2026-01-29
Last Report Date
2025-12-31
Lynch Fair Value
$1.24
Lynch Upside
-93.07
Ma150
14.11
Ma150ch
26.7%
Ma20
15.29
Ma20ch
16.91%
Net CF
762,059,775
Next Earnings Date
2026-05-13
Open
17.88
P FCF Ratio
8.06
P OCF Ratio
6.85
Payment Date
2025-12-11
Ppne
9,757,309,212.5
Price Date
2026-04-17
Price EBITDA
$6.39
Relative Volume
1.15x
Revenue
21,157,112,786x
SBC By Revenue
1.58x
Share Based Comp
334,996,378
Tax By Revenue
2.06x
Tax Rate
44.89%
Tr6m
18.69%
Volume
1,018
Z Score
1.08
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0A87 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.4%
$0.43 annual per share
Payout ratio
+277.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+2.2%
Next ex-dividend date: 2025-09-30
Performance

LON/0A87 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+28.3%
S&P 500 1Y: n/a
3Y total return
+14.5%
S&P 500 3Y: n/a
5Y total return
+13.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0A87?

Insider, institutional, and short-interest positioning.

Institutional ownership
+47.2%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

LON/0A87 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.2
Above 70: short-term overbought
Price vs 200-day MA
+28.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.83
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0A87

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A87 stock rating?

lon/0A87 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A87 analysis?

The full report lives at /stocks/lon/0A87/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A87?

The latest report frames lon/0A87 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A87 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.